Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.

from NYT > Health https://ift.tt/2WnFQqK

0 comments:

Post a Comment

Popular Posts